According to Aeterna Zentaris's latest financial reports the company's total liabilities are $16.2 M. A companyโs total liabilities is the sum of all current and non-current debts and obligations.
Year | Total liabilities | Change |
---|---|---|
2022-12-31 | $20.25 M | -25.32% |
2021-12-31 | $27.11 M | 13.96% |
2020-12-31 | $23.79 M | 6.01% |
2019-12-31 | $22.44 M | -2.86% |
2018-12-31 | $23.1 M | -7.5% |
2017-12-31 | $24.97 M | -1.84% |
2016-12-31 | $25.44 M | -14.84% |
2015-12-31 | $29.88 M | -9.31% |
2014-12-31 | $32.95 M | -21.79% |
2013-12-31 | $42.13 M | -43.34% |
2012-12-31 | $74.36 M | -6.95% |
2011-12-31 | $79.91 M | 24.6% |
2010-12-31 | $64.13 M | -16.75% |
2009-12-31 | $77.03 M | -11.32% |
2008-12-31 | $86.86 M | 149.82% |
2007-12-31 | $34.77 M | -22.06% |
2006-12-31 | $44.61 M | -85.62% |
2005-12-31 | $0.31 B | 92.06% |
2004-12-31 | $0.16 B | 49.94% |
2003-12-31 | $0.10 B | -13.45% |
2002-12-31 | $0.12 B | 429.91% |
2001-12-31 | $23.48 M |
Company | Total liabilities | differencediff. | Country |
---|---|---|---|
Novartis NVS | $53.19 B | 328,102.12% | ๐จ๐ญ Switzerland |
Sanofi SNY | $57.61 B | 355,360.27% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $65.67 B | 405,094.97% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | $80.87 M | 398.95% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.64 B | 10,076.83% | ๐บ๐ธ USA |